Suppr超能文献

载脂蛋白B的α(1)结构域野生型和半胱氨酸突变体形式的囊泡结合特性

Vesicle-binding properties of wild-type and cysteine mutant forms of alpha(1) domain of apolipoprotein B.

作者信息

DeLozier J A, Parks J S, Shelness G S

机构信息

Department of Pathology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA.

出版信息

J Lipid Res. 2001 Mar;42(3):399-406.

Abstract

Previous studies demonstrated that structural perturbation of the alpha(1) domain of apolipoprotein B (apoB) blocked the initiation of lipoprotein assembly. We explored the hypothesis that this domain may interact with the inner leaflet of the endoplasmic reticulum membrane in a manner that may nucleate microsomal triglyceride transfer protein-dependent lipid sequestration. ApoB-17 (amino-terminal 17% of apoB), which contains most of the alpha(1) domain, was expressed stably in rat hepatoma cells and recovered from medium in lipid-poor form. On incubation with phospholipid vesicles composed of 1-myristol-2-myristoyl-sn-glycero-3-phosphocholine or 1-palmitoyl-2-oleoyl-sn-gylycero-3-phosphocholine, apoB-17 underwent vesicle binding and was recovered in the d < 1.25 g/ml gradient fraction. To determine whether vesicle binding is disrupted by the same structural perturbations that block lipoprotein assembly in vivo, apoB-17 was subjected to partial and complete chemical reduction. Although normally a soluble peptide, mild reduction of apoB-17 caused its precipitation, suggesting that hydrophobic, solvent-inaccessible domains within the alpha(1) domain of apoB are stabilized by intramolecular disulfide bonds. In contrast to apoB-17 chemically reduced in vitro, forms of apoB-17 bearing pairwise cysteine-to-serine substitutions were recovered in soluble form from transiently transfected COS-1 cell extracts. Although individual disruption of disulfide bond 2 or 4 in apoB-28 and apoB-50 was previously shown to block lipoprotein assembly in vivo, these alterations had no impact on the ability of apoB-17 to bind to phospholipid vesicles in vitro or on its capacity to form recombinant lipoprotein particles. These results suggest that while the vesicle/lipid-binding property of the alpha(1) domain may reflect an essential role required for the initiation of lipoprotein formation, some other aspect of alpha(1) domain function is perturbed by disruption of native disulfide bonds. -- DeLozier, J. A., J. S. Parks, and G. S. Shelness. Vesicle-binding properties of wild-type and cysteine mutant forms of alpha(1) domain of apolipoprotein B. J. Lipid Res. 2001. 42: 399--406.

摘要

先前的研究表明,载脂蛋白B(apoB)α(1)结构域的结构扰动会阻碍脂蛋白组装的起始。我们探讨了这样一种假说,即该结构域可能以内质网膜内小叶相互作用的方式,使微粒体甘油三酯转移蛋白依赖性脂质隔离成核。包含大部分α(1)结构域的ApoB-17(apoB的氨基末端17%)在大鼠肝癌细胞中稳定表达,并以脂质缺乏的形式从培养基中回收。与由1-肉豆蔻酰-2-肉豆蔻酰-sn-甘油-3-磷酸胆碱或1-棕榈酰-2-油酰-sn-甘油-3-磷酸胆碱组成的磷脂囊泡一起孵育时,ApoB-17会与囊泡结合,并在密度<1.25 g/ml的梯度组分中回收。为了确定囊泡结合是否会被体内阻碍脂蛋白组装的相同结构扰动破坏,对ApoB-17进行了部分和完全化学还原。虽然ApoB-17通常是一种可溶性肽,但轻度还原会导致其沉淀,这表明apoB的α(1)结构域内的疏水、溶剂不可及结构域通过分子内二硫键得以稳定。与体外化学还原的ApoB-17不同,带有成对半胱氨酸到丝氨酸取代的ApoB-17形式从瞬时转染的COS-1细胞提取物中以可溶形式回收。虽然先前已表明apoB-28和apoB-50中二硫键2或4的个别破坏会在体内阻碍脂蛋白组装,但这些改变对ApoB-17体外结合磷脂囊泡的能力或其形成重组脂蛋白颗粒的能力没有影响。这些结果表明,虽然α(1)结构域的囊泡/脂质结合特性可能反映了脂蛋白形成起始所需的基本作用,但α(1)结构域功能的某些其他方面会因天然二硫键的破坏而受到干扰。——德洛齐尔,J.A.,J.S.帕克斯,和G.S.谢尔内斯。载脂蛋白Bα(1)结构域野生型和半胱氨酸突变体形式的囊泡结合特性。《脂质研究杂志》。2001年。42: 399 - 406。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验